Collection's Items (Sorted by Issue Date in Descending order): 21 to 40 of 918
Preview | Issue Date | Title | Author(s) |
| 2021 | Are sarcopenia and cognitive dysfunction comorbid after stroke in the context of brain–muscle crosstalk? | Sui, S.X.; Hordacre, B.; Pasco, J.A. |
| 2021 | Using data linkage for national surveillance of clinical quality indicators for dementia care among Australian aged care users | Cations, M.; Lang, C.; Ward, S.A.; Caughey, G.E.; Crotty, M.; Whitehead, C.; Ahern, S.; Maddison, J.; Inacio, M.C. |
| 2021 | Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients | Sallustio, B.C.; Noll, B.D.; Hu, R.; Barratt, D.T.; Tuke, S.J.; Coller, J.K.; Russ, G.R.; Somogyi, A.A. |
| 2021 | Medication-related hospital admissions in aged care residents | Kalisch Ellett, L.M.; Kassie, G.M.; Caughey, G.E.; Pratt, N.L.; Ramsay, E.N.; Roughead, E.E. |
| 2021 | Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomes | Jones, N.R.; Nielsen, S.; Farrell, M.; Ali, R.; Gill, A.; Larney, S.; Degenhardt, L. |
| 2021 | Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C9 and HLA-B genotypes and phenytoin dosing: 2020 update | Karnes, J.H.; Rettie, A.E.; Somogyi, A.A.; Huddart, R.; Fohner, A.E.; Formea, C.M.; Lee, M.T.M.; Llerena, A.; Whirl-Carrillo, M.; Klein, T.E.; Phillips, E.J.; Mintzer, S.; Gaedigk, A.; Caudle, K.E.; Callaghan, J.T. |
| 2021 | Treatment of cystic fibrosis: from gene- to cell-based therapies | Allan, K.M.; Farrow, N.; Donnelley, M.; Jaffe, A.; Waters, S.A. |
| 2021 | Residential medication management reviews in Australian residential aged care facilities | Sluggett, J.K.; Bell, J.S.; Lang, C.; Corlis, M.; Whitehead, C.; Wesselingh, S.L.; Inacio, M.C. |
| 2021 | Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity | Ashton, T.D.; Ngo, A.; Favuzza, P.; Bullen, H.E.; Gancheva, M.R.; Romeo, O.; Parkyn Schneider, M.; Nguyen, N.; Steel, R.W.J.; Duffy, S.; Lowes, K.N.; Sabroux, H.J.; Avery, V.M.; Boddey, J.A.; Wilson, D.W.; Cowman, A.F.; Gilson, P.R.; Sleebs, B.E. |
| 2021 | Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T allele | Bordin Andriguetti, N.; Van Schalkwyk, H.K.; Barratt, D.T.; Tucci, J.; Pumuye, P.; Somogyi, A.A. |
| 2021 | Identifying the core concepts of pharmacology education | Ngo, S.; White, P.J.; Davis, E.A.; Santiago, M.; Angelo, T.; Shield, A.; Babey, A.-M.; Kemp-Harper, B.; Maynard, G.; Al-Sallami, H.S.; Musgrave, I.F.; Fernandes, L.B.; Hinton,, T. |
| 2021 | Defining and unpacking the core concepts of pharmacology education | Santiago, M.; Davis, E.A.; Hinton, T.; Angelo, T.A.; Shield, A.; Babey, A.M.; Kemp-Harper, B.; Maynard, G.; Al-Sallami, H.S.; Musgrave, I.F.; Fernandes, L.B.; Ngo, S.N.T.; Christopoulos, A.; White, P.J. |
| 2020 | Pharmacotherapies for cannabis use disorders: Clinical challenges and promising therapeutic agents | Nielsen, S.; Sabioni, P.; Gowing, L.; Le Foll, B.; Nadar, M.A.; Hurd, Y.L. |
| 2020 | The Requirements of Developing Countries' Health Systems Facing with COVID-19: A Case Study of Iran | Ghanbarzadegan, A.; Bastani, P.; Emadi, F.; Mohammmadpour, M.; Pourmohammadi, K.; Javanmardi, S.; World Congress on Public Health (12 Oct 2020 - 17 Oct 2020 : virtual online) |
| 2020 | Inclusion of older people reflective of real-world clinical practice in cardiovascular drug trials | Caughey, G.E.; Inacio, M.C.; Bell, J.S.; Vitry, A.I.; Shakib, S. |
| 2020 | Data resource profile: the Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia | Larney, S.; Jones, N.; Fiellin, D.A.; Nielsen, S.; Hickman, M.; Dobbins, T.; Murphy, T.; Ali, R.; Degenhardt, L. |
| 2020 | Isolation and biomimetic oxidation of prenylbruceol A, an anticipated meroterpenoid natural product from philotheca myoporoides | Day, A.J.; George, J.H. |
| 2020 | 5-hydroxymethyl-furfural and structurally related compounds block the ion conductance in human aquaporin-1 channels, and slow cancer cell migration and invasion | Chow, P.H.; Kourghi, M.; Pei, J.V.; Nourmohammadi, S.; Yool, A.J. |
| 2020 | Antimicrobial action and reversal of resistance in MRSA by difluorobenzamide derivatives targeted at FtsZ | Chai, W.C.; Whittall, J.J.; Song, D.; Polyak, S.W.; Ogunniyi, A.D.; Wang, Y.; Bi, F.; Ma, S.; Semple, S.J.; Venter, H. |
| 2020 | Development and application of a high-throughput screening assay for identification of small molecule inhibitors of the P. falciparum reticulocyte binding-like homologue 5 protein | Sleebs, B.E.; Jarman, K.E.; Frolich, S.; Wong, W.; Healer, J.; Dai, W.; Lucet, I.S.; Wilson, D.W.; Cowman, A.F. |
Collection's Items (Sorted by Issue Date in Descending order): 21 to 40 of 918